Skip to content
Search

Latest Stories

Pharmacy regulator to recruit new chair

The General Pharmaceutical Council (GPhC) has begun the selection process for a new chair this week to lead its council.

The new chair will work closely with the council, chief executive and registrar and wider senior leadership group to accomplish the regulator’s 'Vision 2030' for ‘safe and effective pharmacy care at the heart of healthier communities'.


The chair will play a key role representing the GPhC, developing important relationships within and outside of the pharmacy professions.

Current GPhC chair, Nigel Clarke said, “Our new chair will have the opportunity to help shape the future of pharmacy and of health professional regulation as we plan for change. If you are interested in being part of this rapidly developing landscape and have the qualities and commitment that we need, we would like to hear from you.”

“The council needs to be alive to the changes and anticipating how they will impact on patients, the professions and how they are regulated,” Clarke said.

Clarke has been serving as chair of the GPhC since March 2014. He was re-appointed by the privy council in March 2018.

The recruitment process will go on till August 2, and seeks applications from both amateur and registrant candidates.

The chair selection panel, chaired by Royal College of Veterinary Surgeons president, Mandisa Greene, will recommend an appointment to the privy council.

GPhC is the independent regulator of more than 55,000 pharmacists, 23,000 pharmacy technicians and 14,000 pharmacy premises in England, Scotland and Wales. It works to assure and improve the standards of care for people using pharmacy services.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less